JP2004527567A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004527567A5 JP2004527567A5 JP2002586947A JP2002586947A JP2004527567A5 JP 2004527567 A5 JP2004527567 A5 JP 2004527567A5 JP 2002586947 A JP2002586947 A JP 2002586947A JP 2002586947 A JP2002586947 A JP 2002586947A JP 2004527567 A5 JP2004527567 A5 JP 2004527567A5
- Authority
- JP
- Japan
- Prior art keywords
- keto
- compound
- composition
- prostaglandin
- prostaglandin compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28772001P | 2001-05-02 | 2001-05-02 | |
| PCT/JP2002/004223 WO2002089812A1 (en) | 2001-05-02 | 2002-04-26 | Composition for treating drug-induced constipation with 15-keto-prostaglandins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004527567A JP2004527567A (ja) | 2004-09-09 |
| JP2004527567A5 true JP2004527567A5 (https=) | 2005-11-17 |
| JP4332353B2 JP4332353B2 (ja) | 2009-09-16 |
Family
ID=23104042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002586947A Expired - Fee Related JP4332353B2 (ja) | 2001-05-02 | 2002-04-26 | １５−ケト−プロスタグランジン類を含む薬物誘発性便秘処置用組成物 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6982283B2 (https=) |
| EP (1) | EP1392318B1 (https=) |
| JP (1) | JP4332353B2 (https=) |
| KR (1) | KR100886598B1 (https=) |
| CN (1) | CN1522147B (https=) |
| AR (2) | AR035237A1 (https=) |
| AT (1) | ATE355067T1 (https=) |
| AU (1) | AU2002251554B2 (https=) |
| BR (1) | BR0209327A (https=) |
| CA (1) | CA2444103C (https=) |
| DE (1) | DE60218451T2 (https=) |
| DK (1) | DK1392318T3 (https=) |
| ES (1) | ES2282408T3 (https=) |
| MX (1) | MXPA03010019A (https=) |
| NO (1) | NO335143B1 (https=) |
| NZ (1) | NZ529187A (https=) |
| PT (1) | PT1392318E (https=) |
| TW (1) | TWI302100B (https=) |
| WO (1) | WO2002089812A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1420794B1 (en) | 2001-08-31 | 2017-12-27 | Sucampo AG | Prostaglandin analogs as chloride channel openers |
| AR037524A1 (es) * | 2001-11-14 | 2004-11-17 | Sucampo Ag | Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion |
| TWI263505B (en) | 2001-11-19 | 2006-10-11 | Sucampo Ag | Pharmaceutical composition comprising a C1C-2 channel opener |
| NZ539582A (en) * | 2002-10-23 | 2007-07-27 | Sucampo Ag | Prostaglandin compounds for the treatment of obesity |
| EP1575596B1 (en) * | 2002-12-27 | 2016-06-22 | Sucampo AG | Derivatives of prostaglandins for treating irritable bowel syndrome and/or functional dyspepsia |
| TWI387454B (zh) * | 2004-09-02 | 2013-03-01 | 蘇坎波公司 | 治療胃腸道疾病之方法及組成物 |
| US9662325B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| US8524731B2 (en) * | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
| ES2714198T3 (es) * | 2005-03-07 | 2019-05-27 | Univ Chicago | Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales |
| RU2468800C2 (ru) * | 2005-04-12 | 2012-12-10 | Сукампо Аг | Комбинированное применение производного простагландина и ингибитора протонового насоса для лечения желудочно-кишечных заболеваний |
| US20090030072A1 (en) * | 2007-07-03 | 2009-01-29 | Sucampo Ag | Pharmaceutical combination of opioid and prostaglandin compound |
| US20090082442A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched lubiprostone |
| US9044510B2 (en) | 2007-11-01 | 2015-06-02 | Washington University | Compositions and methods for treating pruritus |
| US9084815B2 (en) * | 2009-09-16 | 2015-07-21 | Sucampo Ag | Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor |
| US8957024B2 (en) | 2011-07-27 | 2015-02-17 | Washington University | Composition and methods for reducing opioid-induced pruritus |
| KR20140052389A (ko) | 2012-10-24 | 2014-05-07 | 주식회사 아리바이오 | 해양 심층수 또는 염지하수로부터 제조된 고경도의 미네랄 워터를 포함하는 변비 예방, 개선 또는 치료용 조성물 |
| US20140116916A1 (en) | 2012-10-31 | 2014-05-01 | 2294719 Ontario Limited | Therapy for Constipation |
| WO2014159679A1 (en) | 2013-03-12 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using lubiprostone to absorb fluid from the subretinal space |
| CN105777601A (zh) * | 2014-12-26 | 2016-07-20 | 中国人民解放军第二军医大学 | 一种前列地尔衍生物及其药物制剂 |
| AU2017241904A1 (en) * | 2016-03-29 | 2018-10-18 | Colonaryconcepts Llc | Formulations for treating constipation |
| JP6957610B2 (ja) * | 2016-10-06 | 2021-11-02 | スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ | 医薬品用途のための多層ビーズ |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1581886A (en) * | 1977-05-26 | 1980-12-31 | May & Baker Ltd | Prostanol derivatives |
| US5166174A (en) | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
| CA1322749C (en) | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
| US5221763A (en) | 1987-04-30 | 1993-06-22 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
| US5317032A (en) | 1987-10-02 | 1994-05-31 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Prostaglandin cathartic |
| ES2051862T3 (es) * | 1987-10-02 | 1994-07-01 | Ueno Seiyaku Oyo Kenkyujo Kk | Un metodo para producir un medicamento que tiene un efecto catartico. |
| CA2027814C (en) * | 1989-10-20 | 1996-07-30 | Ryuji Ueno | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds |
| TW224942B (https=) | 1990-04-04 | 1994-06-11 | Adka Ueno Kk | |
| ATE174221T1 (de) * | 1990-05-01 | 1998-12-15 | R Tech Ueno Ltd | Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten |
| CA2150287C (en) | 1994-06-03 | 2004-08-10 | Ryuji Ueno | Agent for treating hepato-biliary diseases |
| WO1997047595A1 (en) | 1996-06-10 | 1997-12-18 | R-Tech Ueno, Ltd. | Endothelin antagonist |
| US6414016B1 (en) * | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
| ATE387204T1 (de) * | 2001-05-18 | 2008-03-15 | Sucampo Ag | Zusammensetzung mit induzierendem kathartischen effekt |
-
2002
- 2002-04-25 TW TW091108513A patent/TWI302100B/zh not_active IP Right Cessation
- 2002-04-26 AT AT02720623T patent/ATE355067T1/de active
- 2002-04-26 CN CN028133897A patent/CN1522147B/zh not_active Expired - Lifetime
- 2002-04-26 JP JP2002586947A patent/JP4332353B2/ja not_active Expired - Fee Related
- 2002-04-26 NZ NZ529187A patent/NZ529187A/en not_active IP Right Cessation
- 2002-04-26 AU AU2002251554A patent/AU2002251554B2/en not_active Expired
- 2002-04-26 PT PT02720623T patent/PT1392318E/pt unknown
- 2002-04-26 KR KR1020037014221A patent/KR100886598B1/ko not_active Expired - Lifetime
- 2002-04-26 CA CA2444103A patent/CA2444103C/en not_active Expired - Lifetime
- 2002-04-26 EP EP02720623A patent/EP1392318B1/en not_active Expired - Lifetime
- 2002-04-26 MX MXPA03010019A patent/MXPA03010019A/es active IP Right Grant
- 2002-04-26 ES ES02720623T patent/ES2282408T3/es not_active Expired - Lifetime
- 2002-04-26 BR BR0209327-8A patent/BR0209327A/pt not_active Application Discontinuation
- 2002-04-26 DK DK02720623T patent/DK1392318T3/da active
- 2002-04-26 DE DE60218451T patent/DE60218451T2/de not_active Expired - Lifetime
- 2002-04-26 WO PCT/JP2002/004223 patent/WO2002089812A1/en not_active Ceased
- 2002-04-29 AR ARP020101560A patent/AR035237A1/es not_active Application Discontinuation
- 2002-05-01 US US10/135,397 patent/US6982283B2/en not_active Expired - Lifetime
-
2003
- 2003-10-31 NO NO20034864A patent/NO335143B1/no not_active IP Right Cessation
-
2015
- 2015-06-01 AR ARP150101727A patent/AR100696A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004527567A5 (https=) | ||
| JP2008531468A5 (https=) | ||
| DK2592081T3 (en) | TETRAHYDROCARBOLIN DERIVATIVES | |
| CA2600331A1 (en) | Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases | |
| CA2444103A1 (en) | Composition for treating drug-induced constipation with 15-keto-prostaglandins | |
| JP2005504836A5 (https=) | ||
| JP2009521483A5 (https=) | ||
| JP2006521359A5 (https=) | ||
| RU2002103597A (ru) | Композиция для лечения нарушений внешней секреции | |
| JP2006513232A5 (https=) | ||
| JP2004507521A5 (https=) | ||
| JP2011516511A5 (https=) | ||
| AR110149A2 (es) | Composición catártica | |
| EA200970582A1 (ru) | ПРОИЗВОДНЫЕ 5-[4-(АЗЕТИДИН-3-ИЛОКСИ)ФЕНИЛ]-2-ФЕНИЛ-5Н-ТИАЗОЛО[5,4-c]ПИРИДИН-4-ОНА И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ РЕЦЕПТОРОВ MCH | |
| RU2018113296A (ru) | Фармацевтическая композиция, содержащая 11-дезокси-простагландиновое соединение и способ стабилизации этого соединения | |
| JP2004529960A5 (https=) | ||
| WO2000048989A1 (en) | Mevinolin derivatives | |
| JP2006506381A5 (https=) | ||
| EA200701035A1 (ru) | Замещенные n-сульфониламинобензил-2-феноксиацетамидные соединения | |
| JP2008528440A5 (https=) | ||
| JP2007518685A5 (https=) | ||
| JP2008533195A5 (https=) | ||
| JP2004519412A5 (https=) | ||
| JP4990620B2 (ja) | ７−置換カンプトテシンおよびカンプトテシン類似体ならびにそれらの調製方法 | |
| RU2006122935A (ru) | Новые производные бензимидазола и имидазопиридина и их применение в качестве лекарственных средств |